KATHRYN MARIE EVANS
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant OGDEN, UT NPI 1164825618
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant UT Amarin Pharma Inc. All categories
General Payments — all program years on this page
$125.16
- Category: General Payments
- Program years: PY2021
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $125.16 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $125.16 | 8 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amarin Pharma Inc. | $34.47 | 2 |
| Corcept Therapeutics | $30.92 | 2 |
| Merck Sharp & Dohme Corporation | $19.70 | 1 |
| Novo Nordisk AS | $14.62 | 1 |
| Esperion Therapeutics, Inc. | $13.10 | 1 |
| Insulet Corporation | $12.35 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2021 | $125.16 | 8 |
Records — PY2021 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 810817595 | Novo Nordisk Inc | $14.62 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 815262499 | Amarin Pharma Inc. | $18.18 | 01/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 815262501 | Amarin Pharma Inc. | $16.29 | 03/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 837539565 | Corcept Therapeutics | $17.35 | 02/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 837539567 | Corcept Therapeutics | $13.57 | 03/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 838471139 | Esperion Therapeutics, Inc. | $13.10 | 02/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 839821981 | Insulet Corporation | $12.35 | 01/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848657623 | Merck Sharp & Dohme Corporation | $19.70 | 01/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.